- Home
- PHVS vs CHY Comparison
PHVS vs CHY Comparison
Compare PHVS & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- CHY
- Stock Information
- Founded
- PHVS 2015
- CHY 2003
- Country
- PHVS Switzerland
- CHY United States
- Employees
- PHVS N/A
- CHY N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- CHY Investment Managers
- Sector
- PHVS Health Care
- CHY Finance
- Exchange
- PHVS Nasdaq
- CHY Nasdaq
- Market Cap
- PHVS 980.9M
- CHY 839.8M
- IPO Year
- PHVS 2021
- CHY N/A
- Fundamental
- Price
- PHVS $22.32
- CHY $11.00
- Analyst Decision
- PHVS Buy
- CHY
- Analyst Count
- PHVS 6
- CHY 0
- Target Price
- PHVS $37.17
- CHY N/A
- AVG Volume (30 Days)
- PHVS 33.8K
- CHY 128.3K
- Earning Date
- PHVS 08-13-2025
- CHY 01-01-0001
- Dividend Yield
- PHVS N/A
- CHY 10.11%
- EPS Growth
- PHVS N/A
- CHY N/A
- EPS
- PHVS N/A
- CHY N/A
- Revenue
- PHVS N/A
- CHY N/A
- Revenue This Year
- PHVS N/A
- CHY N/A
- Revenue Next Year
- PHVS N/A
- CHY N/A
- P/E Ratio
- PHVS N/A
- CHY N/A
- Revenue Growth
- PHVS N/A
- CHY N/A
- 52 Week Low
- PHVS $11.51
- CHY $9.97
- 52 Week High
- PHVS $25.76
- CHY $12.16
- Technical
- Relative Strength Index (RSI)
- PHVS 73.31
- CHY 66.03
- Support Level
- PHVS $17.63
- CHY $10.96
- Resistance Level
- PHVS $19.00
- CHY $11.11
- Average True Range (ATR)
- PHVS 1.20
- CHY 0.09
- MACD
- PHVS 0.35
- CHY 0.01
- Stochastic Oscillator
- PHVS 92.15
- CHY 81.36
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.